A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...
Moorfields hospital in London is the world's first dedicated clinic for the disorder and seven out of eight patients given ...
Everyday Health on MSN
IVIg to SCIg: Considerations When Switching Immunoglobulin Therapies for Primary Immunodeficiency
Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, ...
At many health systems, infusion services operate across multiple sites with varying workflows and approval processes. At ...
St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...
India Today on MSN
Exclusive | Five states, same story: How private hospitals gamble with patients' lives
The moment a patient is admitted, billing begins, often leaving families paying hefty sums despite inadequate care and ...
The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first ...
News Medical on MSN
World-first project shows great promise to treat low eye pressure
A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...
New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound ...
Results of the SPACE trial demonstrating the safety and efficacy of subcutaneous fremanezumab for the prevention of pediatric ...
The pill version of Wegovy could be a game-changer for GLP-1 medications. Unlike the injectable form, it doesn't require ...
Researchers have explored potential treatment that could bring unexpected relief to people living with severe vision loss.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback